Related Experiment Video
Updated: May 22, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone
Vijay S Thakur1, Karishma Gupta, Sanjay Gupta
1Department of Urology and Nutrition, Case Western Reserve University, Cleveland, OH 44106, USA.
Abstract:
Acetylation of the tumor suppressor gene p53 at the carboxy-terminal lysine (Lys) residues enhances its transcriptional activity associated with cell cycle arrest and apoptosis. Histone deacetylases (HDACs), a family of evolutionarily conserved enzymes, counterbalance the acetylation of lysine residues on histone and non-histone proteins. In this study, we demonstrate that green tea polyphenols (GTPs) and their major constituent, (-) epigallocatechin-3-gallate (EGCG), activate p53 through acetylation at the Lys373 and Lys382 residues by inhibiting class I HDACs in LNCaP human prostate cancer cells. Treatment of cells with GTPs (2.5-10 µg/ml) and EGCG (5-20 µM) resulted in dose- and time-dependent inhibition of class I HDACs (HDAC1, 2, 3 and 8), albeit at varying levels. Discontinuation of treatment with GTP/EGCG resulted in the loss of p53 acetylation at both the sites in these cells. GTP/EGCG treatment also resulted in increased expression of p21/waf1 and Bax at the protein and message levels in these cells. The increased GTP/EGCG-mediated p53 acetylation enhanced its binding on the promoters of p21/waf1 and Bax, which was associated with increased accumulation of cells in the G0/G1 phase of the cell cycle and induction of apoptosis. Our findings indicate that GTP/EGCG causes acetylation of p53 by inhibiting class I HDACs, a function that is likely to be part of the mechanisms that control the physiological activity of p53.
Insights
Green tea polyphenols (GTPs) and EGCG activate the tumor suppressor p53 by inhibiting histone deacetylases (HDACs) in prostate cancer cells. This leads to increased cell cycle arrest and apoptosis, suggesting a therapeutic mechanism.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- The tumor suppressor p53's activity is regulated by post-translational modifications like acetylation.
- Histone deacetylases (HDACs) remove acetyl groups, counteracting acetylation and influencing gene expression.
- Prostate cancer cells (LNCaP) provide a model to study p53 regulation.
Purpose of the Study:
- To investigate the effect of green tea polyphenols (GTPs) and epigallocatechin-3-gallate (EGCG) on p53 acetylation.
- To determine if GTPs/EGCG inhibit HDACs in prostate cancer cells.
- To elucidate the downstream effects of GTP/EGCG-induced p53 acetylation on cell cycle and apoptosis.
Main Methods:
- Treatment of LNCaP cells with varying concentrations and durations of GTPs and EGCG.
- Assay of class I HDAC (HDAC1, 2, 3, 8) activity.
- Western blot analysis for p53 acetylation at Lys373 and Lys382, and expression of p21/waf1 and Bax.
- Cell cycle analysis and apoptosis assays.
Main Results:
- GTPs and EGCG dose- and time-dependently inhibited class I HDACs in LNCaP cells.
- Treatment led to increased p53 acetylation at Lys373 and Lys382, with sustained effects.
- Upregulation of p21/waf1 and Bax expression and enhanced p53 binding to their promoters were observed.
- Increased G0/G1 cell cycle arrest and apoptosis were induced by GTP/EGCG treatment.
Conclusions:
- GTPs and EGCG activate p53 acetylation by inhibiting class I HDACs in prostate cancer cells.
- This mechanism contributes to the anti-cancer effects of green tea components, including cell cycle arrest and apoptosis.
- The findings highlight a potential therapeutic strategy involving green tea extracts for prostate cancer treatment.
Related Concept Videos
Abnormal Proliferation
Cell Specific Gene Expression
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

